title: Sezary cell-like leukemia: a distinct type of mature T cell malignancy.
abstract: We describe the clinical, ultrastructural, and immunophenotypical characteristics of four cases of an unusual type of T cell leukemia. Clinical features included high WBC, ranging from 26-148 x 10(9)/liter, bone marrow infiltration, splenomegaly, and lymphadenopathy. Skin involvement was not documented at presentation, but it was seen as a terminal event in one patient with a pattern of dermal lymphocytic infiltration different from that usually seen in Sezary syndrome. By ultrastructural analysis, the circulating lymphoid cells were indistinguishable from small Sezary cells in two cases, resembled large Sezary cells in one case, and consisted of a mixture of small Sezary cells and prolymphocytes in the remaining case. The cells from all cases had a mature T cell phenotype, TdT-, CD1a-, CD2+/-, CD3+, CD5+. In addition, the cells were either CD8+, CD4- or CD8+, CD4+ or CD4-, CD8-; and, in only one case, the findings were similar to those of Sezary syndrome cells: CD4+, CD8-, CD7-, BE-2+. In the latter case, serological and immunological assays were positive for HTLV-I while these were negative in two other patients investigated. The features of these patients suggest that Sezary cell leukemia is a distinct clinico-pathological entity although the alternative diagnosis of adult T cell leukemia/lymphoma could not be excluded in the HTLV-I+ case. Sezary cell leukemia appears to be resistant to current chemotherapy regimens and is associated with an aggressive clinical course and short survival.
authors.affiliation: Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, London, U.K.
authors.forename: E
authors.initials: E
authors.lastname: Matutes
authors.forename: D M
authors.initials: DM
authors.lastname: Keeling
authors.forename: A C
authors.initials: AC
authors.lastname: Newland
authors.forename: C S
authors.initials: CS
authors.lastname: Scott
authors.forename: D
authors.initials: D
authors.lastname: Mitchell
authors.forename: N
authors.initials: N
authors.lastname: Traub
authors.forename: D G
authors.initials: DG
authors.lastname: Wardle
authors.forename: D
authors.initials: D
authors.lastname: Catovsky
authors.forename: D M
authors.initials: DM
authors.lastname: Kelling
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D005260:Female; D015481:HTLV-I Antibodies / Q000276:immunology; D006801:Humans; D015458:Leukemia, T-Cell / Q000097:blood / Q000473:pathology*; D008232:Lymphoproliferative Disorders / Q000097:blood / Q000473:pathology; D008297:Male; D008566:Membranes / Q000276:immunology; D008854:Microscopy, Electron; D008875:Middle Aged; D010641:Phenotype; D012751:Sezary Syndrome / Q000097:blood / Q000235:genetics / Q000473:pathology*
chemical_list: D014408:Biomarkers, Tumor; D015481:HTLV-I Antibodies